Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-1308-2025

Aesculap Inc recalls Numerous models of nonsterile hemostatic forceps: (1) REF BJ500R

Aesculap IncCenter Valley, PA, United StatesReported Mar 19, 2025 · 1 year ago
Legal News Analyst ·

Reason for recall

The forceps have been used in ways not covered by the design resulting in breakage of the clamps.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Numerous models of nonsterile hemostatic forceps: (1) REF BJ500R, Phaneuf Hysterectomy Forceps STR 210MM; (2) REF BJ501R, Phaneuf Hysterectomy Forceps ANG 205MM; (3) REF BJ511R, Holzbach Hyst Forceps CVD245MM; (4) REF BJ520R, Heaney Hyst Forceps Grooved 205MM; (5) REF BJ521R, Heaney Hyst Forceps Grooved 250MM; (6) REF BJ522R, Heaney Hyst Forceps Grooved 195MM; (7) REF BJ524R, Heaney-Rezek Fcpsstr Ser Lgth 210MM; (8) REF BJ527R, Wiener Hyst Forceps Grooves 240MM; (9) REF BJ530R, Heaney Hysterectomy Forceps STR 225MM; (10) REF BJ531R, Heaney Hysterectomy Forceps CVD200MM; (11) REF BJ532R, Heaney Hysterectomy Forceps CVD215MM; (12) REF BJ534R, Hysterectomy For.Gwilliamsstr.205MM; (13) REF BJ550R, Wertheim Parametrium Clamp STR 250MM; (14) REF BJ551R, Wertheim Parametrium Clamp CVD245MM; (15) REF BJ552R, Wertheim Parametrium Clamp CVD240MM; (16) REF BJ553R, Wertheim Parametrium Clamphvy-CVD220MM; (17) REF MD591, Heany Ballentine Hyst Fcps STR.215MM; and (18) REF MD592, Heany Ballentine Hyst Fcps CVD.215MM.

Lot / code information

GTIN
(1)
REF
BJ500R - 04038653139378; (2)
REF
BJ501R - 04038653139385; (3)
REF
BJ511R - 04038653139392; (4)
REF
BJ520R - 04038653139408; (5)
REF
BJ521R - 04038653139415; (6)
REF
BJ522R - 04038653139422; (7)
REF
BJ524R - 04046963364250; (8)
REF
BJ527R - 04038653139446; (9)
REF
BJ530R - 04038653139453; (10)
Show 9 more code fields
REF
BJ531R - 04038653139460; (11)
REF
BJ532R - 04038653139477; (12)
REF
BJ534R - 04038653027798; (13)
REF
BJ550R - 04038653139484; (14)
REF
BJ551R - 04038653139491; (15)
REF
BJ552R - 04038653139507; (16)
REF
BJ553R - 04038653139514; (17)
REF
MD591 - 04046963365592; and (18)
REF
MD592 - 04046963365608

What the firm is doing

The recalling firm issued letters dated 1/29/2025 on 1/31/2025 via certified mail return-receipt. The letter explained the reason for the correction, identified the product impacted, provided the risk to health, and the actions required for the customer/user. The actions included: (1) Review the Urgent Medical Device Correction Notification in its entirety and ensure all users within the consignee organization are informed about the correction. Post the notification where the affected products are stored. If the consignee is a distributor, they are to forward the notification to their customers. The correction is to be extended to the end user/customer level; (2) Determine the current inventory of the affected items and comply with the following instructions: (a) Use the products identified for clamping of tissue and small vessels only; (b) Inspect the products for end-of-life indicators prior to use; (c) Visually inspect the products which should be clean and free of any signs of corrosion and cracks. Check the joint and jaw in the open position from both sides (if needed, use magnification; (d) Test the function of the device, including the jaw area, for deformation and loss of tension. An Acknowledgment Form was enclosed for completion and return via FAX or email within 2 weeks of receipt, even if the total inventory in the consignee location is 0.

DistributionShow details

Distribution was made nationwide and to PR. There was also government/military distribution. Foreign distribution was made to Canada, Bermuda, Bahamas, and Qatar.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls